AusperBio
AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treat a wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
Domain
ausperbio.com
Country
United StatesIndustry
BiopharmaEmployees
101-250
Last Funding
$63.0M
Founded
2018
Tech Stack (3 technologies)
Frequently Asked Questions
What technologies does AusperBio use?+
AusperBio uses 3 technologies including core-js, Element UI, Tengine.
What industry is AusperBio in?+
AusperBio operates in the Biopharma industry.
Where is AusperBio based?+
AusperBio is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026